- Home
- RAPT vs CGO Comparison
RAPT vs CGO Comparison
Compare RAPT & CGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- CGO
- Stock Information
- Founded
- RAPT 2015
- CGO 2004
- Country
- RAPT United States
- CGO United States
- Employees
- RAPT N/A
- CGO N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- CGO Investment Managers
- Sector
- RAPT Health Care
- CGO Finance
- Exchange
- RAPT Nasdaq
- CGO Nasdaq
- Market Cap
- RAPT 117.5M
- CGO 105.3M
- IPO Year
- RAPT 2019
- CGO N/A
- Fundamental
- Price
- RAPT $0.79
- CGO $9.82
- Analyst Decision
- RAPT Hold
- CGO
- Analyst Count
- RAPT 7
- CGO 0
- Target Price
- RAPT $5.00
- CGO N/A
- AVG Volume (30 Days)
- RAPT 1.1M
- CGO 34.7K
- Earning Date
- RAPT 05-08-2025
- CGO 01-01-0001
- Dividend Yield
- RAPT N/A
- CGO 9.25%
- EPS Growth
- RAPT N/A
- CGO N/A
- EPS
- RAPT N/A
- CGO N/A
- Revenue
- RAPT N/A
- CGO N/A
- Revenue This Year
- RAPT N/A
- CGO N/A
- Revenue Next Year
- RAPT N/A
- CGO N/A
- P/E Ratio
- RAPT N/A
- CGO N/A
- Revenue Growth
- RAPT N/A
- CGO N/A
- 52 Week Low
- RAPT $0.79
- CGO $7.90
- 52 Week High
- RAPT $8.58
- CGO $10.93
- Technical
- Relative Strength Index (RSI)
- RAPT 31.31
- CGO 44.33
- Support Level
- RAPT $0.81
- CGO $9.70
- Resistance Level
- RAPT $0.98
- CGO $10.20
- Average True Range (ATR)
- RAPT 0.10
- CGO 0.40
- MACD
- RAPT -0.03
- CGO 0.04
- Stochastic Oscillator
- RAPT 7.72
- CGO 64.16
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About CGO Calamos Global Total Return Fund
Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in equities, convertible securities, and high-yield corporate bonds.